Table of Contents
1. Market Overview
1.1 Product Overview and Scope of Market
1.2 Global Market of Tuberculosis Drugs
2. Market Insights by Product Type
2.1 Market Revenue by Product Types:
2.1.1 Table Market Revenue (in million USD) by Product Types (Historic Data)
2.1.2 Graph Market Revenue ( in million USD) by Product Types (Current & Forecast Data)
2.1.3 Graph Market Share (%) by Product Types in 2018
2.2 Market Volume by Product Types:
2.2.1 Table Market Volume (in million Units) by Product Types (Historic Data)
2.2.2 Graph Market Volume ( in million Units) by Product Types (Current & Forecast Data)
2.2.3 Graph Market Share (%) by Product Types in 2018
2.3 First-line Anti-TB Drugs Market Analysis
2.3.1 Graph Global First-line Anti-TB Drugs Market Revenue (in million USD ) (2018-26)
2.3.2 Graph Global First-line Anti-TB Drugs Market Volume (in million units ) (2018-26)
2.3.3 Table First-line Anti-TB Drugs Market Geographical Analysis
2.4 Second-line Anti-TB Drugs Market Analysis
2.4.1 Graph Second-line Anti-TB Drugs Market Revenue (in million USD) (2018-26)
2.4.2 Graph Global Second-line Anti-TB Drugs Market Volume (in million Units ) (2018-26)
2.4.3 Table Second-line Anti-TB Drugs Market Geographical Analysis
3. Market Segment by Applications
• New Patients
• Drug Resistant TB Patients
3.1 Table Market Revenue (in million USD) by Application (Historic Data)
3.2 Table Market Revenue (in million USD) by Application (Current & Forecast Data)
3.3 New Patients application/ end user analysis
3.3.1 Graph Global New Patients Revenue (in million USD ) (2018-26)
3.3.2 Table Global New Patients Geographical Analysis
3.4 Drug Resistant TB Patients
3.4.1 Graph Global Drug Resistant TB Patients Revenue (in million USD ) (2018-26)
3.4.2 Table Global Drug Resistant TB Patients Geographical Analysis
4. Regional Market Analysis
4.1.1 Global Market Revenue (In Million) and Growth Rate Comparison by Regions (2018-2026)
4.1. North America Tuberculosis Drugs Market Analysis(2018-26)
4.1.1 USA
4.1.2 Canada
4.1.3 Mexico
4.2 Europe Tuberculosis Drugs Market Revenue Forecast (2018-27)
4.2.1 UK
4.2.2 Germany
4.2.3 France
4.2.4 Italy
4.2.5 Rest Of Europe
4.3 APAC Tuberculosis Drugs Market Revenue Forecast (2018- 2026)
4.3.1 China
4.3.2 Japan
4.3.3 India
4.3.4 Singapore
4.3.5 Malaysia
4.3.6 Rest Of APAC
4.4 Rest Of the World (ROW) Market Revenue Forecast (2018-2026)
4.4.1 Africa
4.4.2 Middle East
4.4.3 South America
5. Competitive Analysis
5.1 Sanofi
5.1.1 Overview :
5.1.2 Basic Company Information:
5.1.3 Financial Overview
5.1.3 Production Overview
5.1.4 Geography Revenue Mix ( 2018)
5.1.5Business Revenue Mix
5.1.6 Recent Development
5.2 Pfizer
5.2.1 Overview :
5.2.2 Basic Company Information:
5.2.3 Financial Overview
5.2.4 Production Overview
5.2.5 Geography Revenue Mix ( 2018)
5.2.6 Business Revenue Mix
5.2.7 Recent Development
• Janssen Products
• Otsuka
• AstraZeneca
• Lupin Pharmaceuticals
• Akorn
• STI Pharma
• Sandoz
• Labatec Pharma SA
• Archivel Farma
• BioMerieux
• Cepheid
• Epistem
6. Research Findings and Conclusion
6.1 Research Finding:
6.2 Conclusion:
7. Methodology and Data Source
7.1 Methodology/Research Approach
7.2 Research Programs/Design
7.3 Market Size Estimation
7.4 Market Breakdown and Data Triangulation
7.5 Data Source
7.5.1 Secondary Sources
7.5.2 Primary Sources
7.6 Disclaimer